Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Invest. 2013 May;31(4):215-20. doi: 10.3109/07357907.2012.700986. Epub 2013 Mar 8.

Leukemic stem cells: a review.

Author information

1
Department of Medical Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA. Jenny.Obrien@duke.edu

Abstract

A small subset of cells in a patient with leukemia, termed leukemic stem cells (LSCs) have been shown to be responsible for the proliferation of disease. LSCs are thought to derive from normal hematopoietic stem cells, but are phenotypically distinguishable in that they are CD90(-), CD117(-), and CD123(+). Research in mouse models provides several potential therapeutics to target these cells in human patients. Eliminating LSCs should provide an efficient, potentially curative treatment option for leukemia patients.

PMID:
23473080
DOI:
10.3109/07357907.2012.700986
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center